These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3859364)

  • 1. Cytotoxicity of monoclonal antibodies against individually immunophenotyped human leukemic cells.
    Beksac M; Porwit-Ksiazek A; Hast R; Biberfeld P; Reizenstein P
    Cancer Immunol Immunother; 1985; 19(3):231-6. PubMed ID: 3859364
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia.
    Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B
    Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A bispecific antibody enhances cytokine-induced killer-mediated cytolysis of autologous acute myeloid leukemia cells.
    Kaneko T; Fusauchi Y; Kakui Y; Masuda M; Akahoshi M; Teramura M; Motoji T; Okumura K; Mizoguchi H; Oshimi K
    Blood; 1993 Mar; 81(5):1333-41. PubMed ID: 8095165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid-specific monoclonal antibodies and drugs in combination.
    Lemoli RM; Gasparetto C; Scheinberg DA; Moore MA; Clarkson BD; Gulati SC
    Blood; 1991 Apr; 77(8):1829-36. PubMed ID: 2015406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the ability of monoclonal antibodies to selectively mediate complement-dependent cytotoxicity of human myelogenous leukemia blast cells.
    Ball ED; Kadushin JM; Schacter B; Fanger MW
    J Immunol; 1982 Mar; 128(3):1476-81. PubMed ID: 6948897
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique.
    Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD
    Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reactivity profiles of leukemic myeloblasts with monoclonal antibodies directed to sialosyl-Le(x) and other lacto-series type 2 chain antigens:absence of reactivity with normal hematopoietic progenitor cells.
    Muroi K; Suda T; Nojiri H; Ema H; Amemiya Y; Miura Y; Nakauchi H; Singhal A; Hakomori S
    Blood; 1992 Feb; 79(3):713-9. PubMed ID: 1370643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc gamma RI (MoAb 32).
    Ball ED; Guyre PM; Mills L; Fisher J; Dinces NB; Fanger MW
    J Hematother; 1992; 1(1):85-94. PubMed ID: 1365020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lysis of fresh leukemic blasts by interferon-activated human natural killer cells.
    Pattengale PK; Sundstrom C; Yu AL; Levine A
    Nat Immun Cell Growth Regul; 1983-1984; 3(4):165-80. PubMed ID: 6597341
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An antigen shared by human granulocytes, monocytes, marrow granulocyte precursors and leukemic blasts.
    Shumak KH; Rachkewich RA
    Acta Haematol; 1983; 69(3):164-70. PubMed ID: 6404099
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactate dehydrogenase-release assay: a reliable, nonradioactive technique for analysis of cytotoxic lymphocyte-mediated lytic activity against blasts from acute myelocytic leukemia.
    Weidmann E; Brieger J; Jahn B; Hoelzer D; Bergmann L; Mitrou PS
    Ann Hematol; 1995 Mar; 70(3):153-8. PubMed ID: 7718644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antigenic determinants on myeloid leukaemia colony-forming cells resemble those of normal myeloid progenitor cells and differ from those of circulating blast cells.
    Robak T; Dowding C; Garewal G; Hibbin JA; Th'ng KH; Goldman JM
    Br J Haematol; 1986 Sep; 64(1):133-48. PubMed ID: 2428394
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of anti-myeloid antibodies on the generation of hematopoietic colony-forming units in long-term bone marrow culture.
    Ball ED; Keefe KA; McDermott JM
    Bone Marrow Transplant; 1989 May; 4(3):309-15. PubMed ID: 2659116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Pan-myeloid" reagent: the monoclonal antibody MCS-2 in the routine immunodiagnostic service of leukemia phenotyping.
    Drexler HG; Sagawa K; Menon M; Minowada J
    Jpn J Cancer Res; 1985 Mar; 76(3):235-9. PubMed ID: 3922842
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous bone marrow transplantation in acute myelogenous leukemia: in vitro treatment with myeloid cell-specific monoclonal antibodies.
    Ball ED; Mills LE; Coughlin CT; Beck JR; Cornwell GG
    Blood; 1986 Dec; 68(6):1311-5. PubMed ID: 3535927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Normal and malignant human myelocytic and monocytic cells identified by monoclonal antibodies.
    Bernstein ID; Andrews RG; Cohen SF; McMaster BE
    J Immunol; 1982 Feb; 128(2):876-81. PubMed ID: 6948042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The expression of myeloid-specific antigens on myeloid leukemia cells: correlations with leukemia subclasses and implications for normal myeloid differentiation.
    Ball ED; Fanger MW
    Blood; 1983 Mar; 61(3):456-63. PubMed ID: 6186318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specificity of heteroantisera to human acute leukemia-associated antigens.
    Baker MA; Ramachandar K; Taub RN
    J Clin Invest; 1974 Dec; 54(6):1273-8. PubMed ID: 4140196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody.
    Ball ED; Graziano RF; Fanger MW
    J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoclonal antibody-mediated cytotoxicity of human myeloid leukemia cells: an in vitro model for estimating efficiency and optimal conditions for cytolysis.
    Howell AL; Ball ED
    Blood; 1985 Sep; 66(3):649-54. PubMed ID: 3861203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.